Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Leah Labs
AddedFeb 19, 2024
UpdatedJul 3, 2026
Leah Labs

Leah Labs

Angel

LEAH Labs: Pioneering pet cancer care with precision CAR-T cell therapy.

HQ
Rochester, MN, US
Founded
2018
Accelerator
Y Combinator logoY CombinatorW19
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to revolutionize pet healthcare, LEAH Labs focuses on engineering living therapies for pets, particularly targeting cancer. Utilizing virus-free gene editing technology, the company aims to develop CAR-T cell therapy for dogs, addressing an unmet need in companion animal medicine while also creating a platform to discover and de-risk potential human treatments. Their market focus includes pet owners and veterinary professionals, with a particular emphasis on treating B cell lymphoma in dogs.

Notable affiliations include partnerships with the University of Minnesota, Ohio State University, University of Missouri, and North Carolina State University. LEAH Labs has achieved significant milestones, such as enrolling pet patients in fully funded pilot efficacy trials. By pioneering CAR-T cell therapy for pets, the company not only enhances veterinary care but also contributes valuable insights to human medical research, creating a profound impact on both fields.

Leah Labs - Similar Companies

Curelab Veterinary logo

Curelab Veterinary

Vetigenics logo

Vetigenics

vetigenics.com

Animal Life Sciences logo

Animal Life Sciences

Gallant Pet logo

Gallant Pet

gallant.com

FidoCure® logo

FidoCure®

fidocure.com

Elias Animal Health logo

Elias Animal Health

Rejuvenate Bio logo

Rejuvenate Bio

rejuvenatebio.com

MySimplePetLab logo

MySimplePetLab

mysimplepetlab.com

VetDC logo

VetDC

Alaya.bio logo

Alaya.bio

alaya.bio

Loyal logo

Loyal

loyalfordogs.com

PetDx logo

PetDx

Biotesserae Camunity logo

Biotesserae Camunity

Animal Biosciences logo

Animal Biosciences

Humane Genomics logo

Humane Genomics

humanegenomics.com

Leah Labs - Quick Facts

Who are Leah Labs' competitors?

Companies similar to Leah Labs include Curelab Veterinary, Vetigenics, Animal Life Sciences and Gallant Pet.

When was Leah Labs founded?

Leah Labs was founded in 2018.

Where is Leah Labs' headquarters located?

Leah Labs' headquarters is located in Rochester, MN, US.

When was Leah Labs' last funding round?

Leah Labs' most recent funding round was for $100k (USD) in May 2022.

How much has Leah Labs raised to-date?

As of May 10, 2022, Leah Labs has raised a total of $475k (USD).

How many employees does Leah Labs have?

Leah Labs has 8 employees as of Feb 4, 2024.

Leah Labs - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
  • Gene Editing
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Consumers
Main Product
  • Pet Healthcare